A clinical-stage biotechnology company in regenerative medicine the D Biotherapeutics LLC assembled team are using novel 3D-bioprinting and materials technologies to deliver safe, functional and personalized living tissues and organs, engineered on-demand for patients. Developing living tissue implants with structural and functional integrity with a four-part technology platform, including: novel and proprietary 3D-bioprinter (GMPrint), bio-ink (ColVivo), specialized cell culture system, and implantable protective shell (Overshell Technology), management are committed to providing healthcare professionals with safe and functional implant solutions delivering optimal patient outcomes, management are breaking new ground with a clinical trial underway to treat Microtia, three additional programs nearing the clinic, and multiple life-changing treatment approaches in developme
